project id: TCGA-LUSC; case submitter id: TCGA-21-A5DI; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; rna integrity number: 7.1; age at index: 77; days to birth: -28374; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1929; age at diagnosis: 28374; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 979.0; icd 10 code: C34.3; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: No; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2379; days to sample procurement: 0; initial weight: 220.0; portion submitter id: TCGA-21-A5DI-01A-31; percent lymphocyte infiltration: 70.0; percent monocyte infiltration: 10.0; percent necrosis: 10.0; percent neutrophil infiltration: 5.0; percent normal cells: 30.0; percent stromal cells: 20.0; percent tumor cells: 40.0; percent tumor nuclei: 60.0;